Detalhe da pesquisa
1.
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.
Pituitary
; 16(2): 220-30, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22806554
2.
Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis.
BMC Pharmacol Toxicol
; 18(1): 22, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28372573
3.
Prostate brachytherapy can be performed in selected patients after transurethral resection of the prostate.
Int J Radiat Oncol Biol Phys
; 59(2): 392-6, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15145153
4.
Patient perspectives on the impact of acromegaly: results from individual and group interviews.
Patient Prefer Adherence
; 8: 53-62, 2014 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24453479
5.
Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.
J Clin Endocrinol Metab
; 99(12): 4712-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25210883